Olmesartan in Essential Hypertension

NCT00185172 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2333

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

OTHER: placebo
DRUG: olmesartan medoxomil
DRUG: olmesartan medoxomil oral tablets, hydrochlorothiazide oral tablets

Sponsor

Sankyo Pharma Gmbh